Apogee Therapeutics

About:

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Website: https://apogeetherapeutics.com/

Top Investors: RA Capital Management, OrbiMed, Fidelity, Perceptive Advisors, RTW Investments

Description:

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.

Total Funding Amount:

$652M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

San Francisco, California, United States

Founded Date:

2022-01-01

Founders:

Nimish Shah

Number of Employees:

101-250

Last Funding Date:

2024-03-07

IPO Status:

Public

© 2025 bioDAO.ai